Let’s Advance LQTS Research Together
Join myQTWave
MyQTWave
is a non-interventional, observational study designed to better understand the lives of those diagnosed with LQTS Type 2 or 3 and shape the future of care.
-
Non-Interventional
No medications, procedures,
or changes to your current treatment
during the study. -
Developed with Care
MyQTWave was developed by cardiologists, psychologists, and people living with LongQT Syndrome 2 or 3.
-
Make an Impact
Your participation directly contributes
to advancing scientific understanding and better treatments.
What’s Involved?
Reach out to our study team by phone or email to learn more and connect with researchers who can answer your questions.
Contact Us
If you choose to participate, we’ll guide you through a short eligibility screening and informed consent process — all done remotely through secure digital tools.
Get Screened
Participate Flexibly
Complete surveys, ECG scans, and optional symptom tracking at your convenience in the MyQTWave app.
-
Your participation helps researchers better understand the day to day life of people living with LQTS Type 2 and Type 3. Your voice and experience contribute to true patient insights about physical, mental and social health.
-
You may be eligible if:
You have been diagnosed with Long QT Syndrome (LQTS) Type 2 or Type 3
You are 18 years of age or older
You are currently living in the United States
You are able and willing to use a smartphone and wearable device
-
The study is sponsored by Thryv Therapeutics Inc., a biotech company developing new treatments for cardiac conditions including LQTS.
“MyQTwave is founded on the best principles of science and discovery. We want this study to change and direct the future of care for all patients and families dealing with Long QT Syndrome.”
Samuel F. Sears, Jr., PhD - East Carolina University
Ready to apply?
Contact our study coordinator to set up an eligibility screening.
[1-234-567-8900]
Follow us on Instagram!
